MAGICL PIVKA-II (CLIA)

Primary DI

06954414798623

Basic UDI-DI Code

B-06954414798623

Reference

/

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Getein Biotech, Inc.

MAGICL PIVKA-II (CLIA) is intended for the in vitro quantitative determination of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) in human serum, plasma or whole blood. Clinically, it is mainly used for auxiliary diagnosis of HCC (hepato-cellular carcinoma), monitoring the development of HCC, and in management of HCC. For professional and laboratory use only.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).